Information for "Costeffectiveness of gilteritinib regarding relapsedrefractory FLT3mut intense myeloid leukemia"
Jump to navigation
Jump to search
View the protection log for this page.
Basic information
| Display title | Costeffectiveness of gilteritinib regarding relapsedrefractory FLT3mut intense myeloid leukemia |
| Default sort key | Costeffectiveness of gilteritinib regarding relapsedrefractory FLT3mut intense myeloid leukemia |
| Page length (in bytes) | 11,551 |
| Page ID | 943877 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Frownsail48 (talk | contribs) |
| Date of page creation | 07:17, 27 October 2024 |
| Latest editor | Frownsail48 (talk | contribs) |
| Date of latest edit | 07:17, 27 October 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |